ACDcure
ActiveSummary
The computed 12-month bankruptcy probability of ACDcure is 1.9% (moderate). The 2025 annual accounts show negative equity (€-5k) and a net result of €3k. Equity is shrinking by ~64.8% per year across the filed fiscal years. Its solvency ranks better than 14% of 11389 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability88▲+88
Solvency0=
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity ample (current ratio 2.18 against 0.62 in 2024; short-term debt: 42.6% and cash: 30.8% of total assets), but equity is negative.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-30.6%
Return on assets
15.4%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 11389 sector peers (2025).
NBB · sector comparisonPosition among 11389 sector peers
Solvency
better than 14%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
3 d early
2024
1 d early
2023
61 d late
2022
28 d late
2021
31 d late
2020
30 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
History
Financials · fiscal year 2025, micro schema
Equity
€-5k▲ 33.5%
2024 · €-8k
Total assets
€17k▲ 91.1%
2024 · €9k
Net result
€3k
2024 · €-5k
Working capital
€9k
2024 · €-5k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€-2k▲ 62.7%€-5k▼ 240%€-1k▲ 72.1%€-4k▼ 162%€3k
Net result€-2k▲ 58.6%€-5k▼ 214%€-2k▲ 65.5%€-5k▼ 148%€3k
Equity€4k▼ 30.0%€-1k€-3k▼ 134%€-8k▼ 142%€-5k▲ 33.5%
Total assets€13k▲ 8.2%€13k▲ 4.4%€14k▲ 4.5%€9k▼ 35.6%€17k▲ 91.1%
Debt€9k▲ 44.4%€15k▲ 68.3%€17k▲ 16.7%€17k▼ 1.9%€23k▲ 32.8%
Working capital€639▼ 32.4%€-2k€-648▲ 59.4%€-5k▼ 742%€9k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €3k after a loss of €4k in 2024, the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €17k
Fixed assets
€1k ▲ 253%
Current assets
€16k ▲ 84.8%
Key figures and ratios
EBITDA
€3k▲
2024 · €-3k
Cash flow
€3k▲
2024 · €-4k
Solvency
-30.6%▲
2024 · -87.9%
Current ratio
2.18▲
2024 · 0.62
Quick ratio
1.14▲
2024 · 0.30
Debt to equity
-4.27▼
2024 · -2.14
ROA
15.4%▲
2024 · -51.6%
Interest coverage
7.68▲
2024 · -3.84
Debt ≤ 1 year
€7k▼
2024 · €14k
Debt > 1 year
€14k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1k | €1k | €1k | €611 | €448 | ▼ 26.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | - | €1k | - |
| Other operating charges640/8 | €991 | €556 | €580 | €1k | €760 | ▼ 33.5% |
| Gross operating margin9900 | €866 | €-3k | €127 | €-2k | €5k | ▲ 351% |
| Operating profit (loss)9901 | €-2k | €-5k | €-1k | €-4k | €3k | ▲ 178% |
| Financial income75/76B | €0 | €21 | €0 | €65 | €86 | ▲ 31.3% |
| Recurring financial income75 | €0 | €21 | €0 | €65 | €86 | ▲ 31.3% |
| Financial charges65/66B | €181 | €178 | €402 | €853 | €455 | ▼ 46.7% |
| Recurring financial charges65 | €181 | €178 | €402 | €853 | €455 | ▼ 46.7% |
| Profit (loss) for the period before taxes9903 | €-2k | €-5k | €-2k | €-5k | €3k | ▲ 157% |
| Profit (loss) for the period9904 | €-2k | €-5k | €-2k | €-5k | €3k | ▲ 157% |
| Profit (loss) for the period to be appropriated9905 | €-2k | €-5k | €-2k | €-5k | €3k | ▲ 157% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €13k | €13k | €14k | €9k | €17k | ▲ 91.1% |
| Fixed assets21/28 | €3k | €2k | €953 | €342 | €1k | ▲ 253% |
| Intangible fixed assets21 | €2k | €2k | €953 | €342 | - | - |
| Tangible fixed assets22/27 | €1k | €410 | - | - | €1k | - |
| Plant, machinery and equipment23 | €1k | €410 | - | - | €1k | - |
| Current assets29/58 | €9k | €11k | €13k | €9k | €16k | ▲ 84.8% |
| Stocks and contracts in progress3 | €5k | €3k | €5k | €4k | €8k | ▲ 74.7% |
| Stocks30/36 | €5k | €3k | €5k | €4k | €8k | ▲ 74.7% |
| Amounts receivable within one year40/41 | €3k | €8k | €7k | €3k | €3k | ▲ 3.1% |
| Trade receivables40 | €3k | €8k | €7k | €3k | €3k | ▲ 3.1% |
| Cash at bank and in hand54/58 | €2k | €1,000 | €1k | €1k | €5k | ▲ 299% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €13k | €13k | €14k | €9k | €17k | ▲ 91.1% |
| Equity10/15 | €4k | €-1k | €-3k | €-8k | €-5k | ▲ 33.5% |
| Contributions10/11 | €10k | €10k | €10k | €10k | €10k | = |
| Profit (loss) carried forward14 | €-6k | €-11k | €-13k | €-18k | €-15k | ▲ 14.9% |
| Amounts payable17/49 | €9k | €15k | €17k | €17k | €23k | ▲ 32.8% |
| Amounts payable after more than one year17 | - | - | - | - | €14k | - |
| Other amounts payable178/9 | - | - | - | - | €14k | - |
| Amounts payable within one year42/48 | €9k | €13k | €14k | €14k | €7k | ▼ 47.9% |
| Trade debts44 | €4k | €7k | €8k | €4k | €2k | ▼ 43.3% |
| Suppliers440/4 | €4k | €7k | €8k | €4k | €2k | ▼ 43.3% |
| Taxes, remuneration and social security45 | €2k | €1k | €942 | €1k | €481 | ▼ 59.7% |
| Taxes450/3 | €2k | €1k | €942 | €1k | €481 | ▼ 59.7% |
| Other amounts payable47/48 | €3k | €5k | €5k | €9k | €5k | ▼ 48.6% |
| Accrued charges and deferred income492/3 | - | €2k | €4k | €3k | €1k | ▼ 52.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €-2k | €-5k | €-2k | €-5k | €3k | ▲ 157% |
| + Depreciation and write-downs630 | €1k | €1k | €1k | €611 | €448 | ▼ 26.7% |
| Operating cash flow (approximation) | €-306 | €-4k | €-854 | €-4k | €3k | ▲ 177% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €-1k | - |
| Change in cash | - | €-1k | €233 | €105 | €4k | ▲ 3,698% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Back to profitnet €3k
Net result €3k after 5 loss-making years.
31-12
Financial
Liquidity quadruplescurrent ratio 2.18
Current ratio from 0.62 to 2.18; short-term debt falls from €14k to €7k.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
28-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
31-12
Financial
Weakest financial yearnet €-5k
Net result drops to €-5k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nazareth-De Pinte · 1 establishment unit since 2019
Ground area
839 m²
Building footprint
167 m²
Volume, LiDAR
924 m³
Parcel 44012C0390/00H002, Flanders · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
ACDcure
since 20192.297.426.588
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44012C0390/00H002 | Flanders | 839 m² | 1 · 167 m² | 9.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
BO Medical Technologies Belgium
BE 0536.459.290
Machelen (Brab.) · Eq €4,313
Medica BNL
BE 0563.805.273
Jabbeke · Eq €3,813
LIMS Trading
BE 0578.940.639
Sint-Gillis (bij-Brussel) · Eq €4,398
K-RO SOINS INFIRMIERS
BE 0768.721.139
Ham-sur-Heure-Nalinnes · Eq €3,550
Acar'Up
BE 0567.583.523
Sint-Lambrechts-Woluwe · Eq €4,648
Of 1,902 companies in sector 46460 we hold annual accounts for 1,116. 135 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-12-2019
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
68110Buying and selling of own real estate
73300Public relations and communication consultancy
Contact
Website
www.acdcure.com
E-mail
info@acdcure.com
Scores and ratios are computed by Checked and are not a credit decision.